SUPPLEMENTAL FINANCIAL STATEMENT DATA (Tables)

12 Months Ended

Dec. 28, 2024

Disclosure Text Block Supplement [Abstract]

Schedule of Condensed Income Statement Information


Consolidated Statement of Income (Loss) (millions)	2024		2023		2022
Research and development expense	$	24	$	25	$	25
Advertising expense	$	210	$	206	$	178

Schedule of Condensed Balance Sheet Information


Consolidated Balance Sheet (millions)	2024 (Restated)		2023
Trade receivables	$	169	$	225
Allowance for expected credit losses	(1)		—

Other receivables	31		19
Accounts receivable, net	$	199	$	244
Raw Materials	49		49
Manufacturing Supplies	53		53
Materials in process	22		15
Finished goods	243		231
Inventories	$	367	$	348
Land	14		14
Buildings	699		679
Machinery and equipment	1,807		1,799

Construction in progress	234		184
Accumulated depreciation	(1,968)		(1,937)
Property, net	$	786	$	739








Other third party	520		502
Kellanova (a)	—		39
Accounts Payable	$	520	$	541
Obligations under Transition Services Agreement	8		52
Operating lease obligations	18		6
Income taxes payable	17		8
Other	54		40
Other current liabilities	$	97	$	106

(a)The $39 million payable to Kellanova represents various items Kellanova paid on our behalf, for which we owe reimbursement for amounts incurred related to the Spin-Off.